Sermorelin vs HGH: What's the Difference and Which Is Right for You?

Sermorelin stimulates your pituitary to produce growth hormone naturally — unlike HGH injections which replace it directly. A board-certified physician explains the difference, the evidence, the risks, and who is a candidate.

The Core Difference: Stimulate vs. Replace

Human Growth Hormone (HGH): A synthetic version of the growth hormone your pituitary already makes. Injecting it bypasses your body's own production. FDA-approved only for documented growth hormone deficiency, short stature in children, and a handful of other specific conditions. Prescribing HGH for anti-aging or general wellness is off-label and legally prohibited without a qualifying diagnosis — HGH is a controlled substance under the Anabolic Steroid Control Act for non-qualifying uses.
Sermorelin (GHRH 1-29): A synthetic analog of growth hormone-releasing hormone (GHRH) — the signal your hypothalamus naturally sends to tell your pituitary to produce growth hormone. Sermorelin does not replace growth hormone. It stimulates your own pituitary to secrete it in a pulsatile, physiologically regulated pattern.

HGH replacement suppresses your pituitary's own GH production over time. Sermorelin works with your pituitary rather than around it, preserving the feedback architecture that keeps hormone levels in the appropriate physiological range.

Why YourMD Prescribes Sermorelin — Not HGH

YourMD does not prescribe HGH, testosterone, or any controlled substance under any circumstances. Sermorelin is a non-controlled peptide that can be legally compounded by licensed 503A pharmacies and prescribed by any licensed physician for appropriate patients.

Clinical advantages of sermorelin over exogenous HGH:

Preserved negative feedback: Somatostatin (the inhibitory signal) is still released if GH rises too high — this doesn't happen with exogenous HGH.
Pulsatile GH pattern maintained: Normal GH secretion is pulsatile. Sermorelin preserves this rhythm. Exogenous HGH creates a flat non-pulsatile elevation.
Pituitary preserved: Long-term exogenous HGH can downregulate the pituitary's own somatotroph cells. Sermorelin maintains and in some studies appears to restore pituitary reserve.
Significantly lower side effect burden: Acromegaly features, carpal tunnel, fluid retention, insulin resistance, and potential increased cancer risk associated with supraphysiologic HGH are far less likely with sermorelin because levels are physiologically limited.

What Sermorelin Does — The Evidence

GH naturally declines with age — secretion at age 60 is approximately 50% of what it was at age 25. This contributes to body composition changes of aging: reduced lean muscle mass, increased visceral fat, decreased bone density, reduced energy, impaired sleep quality.

Body composition: Studies in older adults show GHRH stimulation reduces visceral fat and increases lean body mass over 6–12 months. Effect sizes are modest but consistent with physiological restoration.
Sleep quality: GHRH peptide administration has been shown in small RCTs to increase slow-wave sleep duration and improve subjective sleep quality.
IGF-1 levels: The most reliable biomarker of GH axis activity reliably increases with sermorelin and can be monitored to avoid supraphysiologic levels.
Important limitation: Most sermorelin studies are small, short duration, and funded by compounding industry sources. No large independent RCT has established long-term efficacy for off-label wellness use. The physiological rationale is sound; the clinical evidence base is early.

Who Is a Candidate

At YourMD, sermorelin is considered for adults 30+ with clinical signs of age-related GH decline who do not have active malignancy, cancer history in the past 5 years, active proliferative diabetic retinopathy, or untreated hypothyroidism. Baseline IGF-1 measurement is required before starting.

Protocol and Pricing